More articles about: COVID-19 Vaccine

COVID-19 tribute sculpture in University Hospital courtyard unveiled on sixth anniversary of announcement that first patient was being treated at U-M Health.

An expert update on vaccinations needed this Fall.

With misinformation and shifting policies around vaccines circulate, Michigan Medicine experts agree that the flu, RSV, and COVID vaccines protect against the worse health outcomes.

COVID-19 vaccination of people over 65 would save the country money, and vaccination of younger groups of adults would be a reasonable investment 

The money spent to develop, test, buy and administer the first COVID-19 vaccine was more than made up for by prevented medical care and lost productivity.

An article about Michigan Medicine's long COVID clinic.

An infectious disease doctor and medical historian details similarities to other epidemics such as syphilis, AIDS and tuberculosis.

Adults, especially people over 65, should get immunized against COVID-19, flu and other infections, to prevent fall and winter illness, hospitalization and worse

Today, thanks to researchers, medical and public health experts, pharmaceutical companies, engineers and others, we know more and can do more about the coronavirus called SARS-CoV2, and the disease called COVID-19, than ever before.

A prospective study published in the journal Lancet Microbe provides more clarity on which patient populations are at higher risk for prolonged infections — and hints that this fear is likely unwarranted.

Vaccination against the coronavirus was much lower in adults and children with sickle cell disease despite a higher risk of severe COVID-19.

Winter surges in infectious diseases can ruin holidays, but vaccination against COVID-19, flu, RSV, whooping cough and pneumonia can help.

It’s not a booster, it’s a new vaccine just in time for respiratory infection season.

The newest COVID vaccine was approved by the Food and Drug Administration and recommended by the Centers for Disease Control and Prevention in September and is rolling out in pharmacies and clinics across the country.

Michigan Medicine researchers looked into a drug in development to treat prostate cancer called proxalutamide, which works by blocking an enzyme called TMPRSS2 (transmembrane protease, serine 2) that is regulated by androgen receptors, as a potential therapeutic for COVID.